Salix Announces Filing Acceptance for Plenvu Next Generation Bowel Cleansing Preparation for Colonoscopies

BRIDGEWATER, N.J. – June 28, 2017 – Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX AND TSX: VRX) wholly owned subsidiary, Salix Pharmaceuticals, a leading specialty pharmaceutical company committed to the prevention and treatment of...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news